STTCOMP AVE FA and TA LONG
AVE - 6 mill market cap with 5 mill in cash, currently conducting phase 3 trials for insomnia. Target audience is huge with 1 in 3 Australians suffering from it.
If results are successful could see a unicorn. Interim results due December 24.
National nine news last night had a story on the company.
From a TA perspective chart setting up well
Thanks
- Forums
- ASX - Short Term Trading
- Short term trading weekly thread 21st October 2024
STTCOMP AVE FA and TA LONGAVE - 6 mill market cap with 5 mill in...
Featured News
Featured News
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online